We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-3.00 | -1.01% | 295.00 | 292.00 | 298.00 | 294.00 | 294.00 | 294.00 | 233 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/1/2011 15:21 | China ageing crisis People aren't just getting older and living longer in the West. They are getting older and living longer all over the world. That includes China. The stock tip that got away from me last year was Hutchison China Meditech (LSE: HCM), a UK pharmaceuticals and biotechnology company that targets the silver China market. It has a market cap of £266 million, and is up 157% after I added it to my watchlist year or so ago. I guess we've missed this opportunity (though I said that back when it had risen 50%) but there must be others out there. This sector may be worth a closer look. | share_shark | |
01/1/2011 12:49 | Both above taken from another thread courtesy, of that posters hard work....not mine. | share_shark | |
01/1/2011 12:48 | www.thisismoney.co.u Mark Slater Entertainment One, Hutchison China Meditech. Cape, Andor Technology, Oxford Instruments, Harry Nimmo Asos Anthony Cross Aegis, BAE | share_shark | |
01/1/2011 09:25 | Happy HERBAL new year | grupo guitarlumber | |
31/12/2010 23:34 | Smoke yourself to death by all means, but don't you dare take any of those nasty herbal remedies!! Just about sums us up, plus the inevitable transition in global influencs from West to East, but Hcm thankfully gives the forward thinking a foot in the progressive camp. | kluk069 | |
30/12/2010 23:39 | GGL I'm hoping this won't impact the share price as most of if not all of their business is in China? | willsy50 | |
21/12/2010 07:47 | Nice summary of HCM's three main areas of activity, and a further chunk of investor interest in one of them: | m.t.glass | |
20/12/2010 08:48 | If anyone's reading this, they may be surprised to know --- | ddav | |
19/12/2010 00:33 | Anyone know much about C & O Pharma, which is a Singapore listed competitor. Price rise not as steep, but does appear to have a stonking 17% dividend!! | kluk069 | |
17/12/2010 11:40 | Risk Management SS - when it comes to scarpering for the hills I dont want to be paying brokers a fortune in commisions. What are the 4 firms you are thinking of? - email to V please. | bongo bwana | |
17/12/2010 08:50 | No prob SS. Will txt you any VIP news. Apart from TNZ dont see any news before Jan. Am VERY happy with portfolio development and its value in 2010. No cash (or otherwise)shells. promising targets too. 2011 will be a year of consolidation into 4 companys - thats my aim but lets see what SCSW amd MI bring to the table eh? | bongo bwana | |
17/12/2010 07:32 | ;=) Many thanks BB. My George Cross has almost fallen off !. Emailer not fully operational. Its that dastardly T x2 Co. Can receive but cannot send. They are working on it they say. | share_shark | |
17/12/2010 06:27 | SS - dont mind the clueless bastaards that suggest you ramp. Ive seen Ur postings on a number of Bb's and Im starttled by the amount of research you must do to mine the information you unearth and produce , here nad elsewhere. OR, are you in MI5 and a half???? | bongo bwana | |
14/12/2010 20:26 | As I said before dnfa -- it's high time you "flu" off!!!!!!!!!!!!!!!! | ddav | |
13/12/2010 20:49 | Courtesy of a poster on another thread.Another company i know but the same sentiments may apply to HCM .INMHO DATFate: 13/12/10 'East meets East' - Chinese VIP highlights Cambridge investment opportunities Tim Mitchell, CEO of Sareum Ltd, a specialist cancer drug discovery business said: "This was a useful opportunity to explain to Minister Counsellor Zhou Xiaoming how we are looking to grow our Cambridge-based business by collaborating with partners in China and for him to hear first hand some of the experiences we have had meeting with these potential partners. China is set to become one of the major players in bio-science innovation and so dialogue with Chinese business leaders at events like this is critical to ensure we continue to work together to improve the intellectual property environment for Chinese and British businesses to ensure innovation and growth." | share_shark | |
12/12/2010 23:41 | Fantastic share price grow and I can see the company is increasing revenues ..... but they have yet to turn a profit? | melody9999 | |
11/12/2010 12:46 | could benefit from bird flu | dnfa1975 | |
10/12/2010 18:45 | In tonight Uk Analyst.PG recci being mentioned in several places I see. Panmure Gordon reiterated its "buy" recommendation for Hutchison China Meditech (HCM), the pharmaceutical and healthcare group, with a 600p target price. The broker continues to find the markets in which the business operates very attractive. The Chinese consumer healthcare market is currently growing at greater than 15%, and is forecast to experience robust growth in the coming decade. That said, Panmure believes that the current valuation does not reflect the combined value of the company's businesses due to its conglomerate structure. Hutchison shares edged up 1.5p to 501.5p. | share_shark |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions